Ozone therapy and routine medical treatment efficacy on serum level changes of TNF-a and CRP as well as neurological improvement
Phase 3
- Conditions
- Ischemic stroke.Transient cerebral ischemic attacks and related syndromesI63.9
- Registration Number
- IRCT20200202046342N1
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Being in the phase of ischemic stroke rehabilitation (NIHSS <15- mRs <5) and being alert to cooperate in the implementation of the plan
At least 2 months have passed since the onset of acute stroke
Exclusion Criteria
Hemorrhagic stroke
Cancer
Active infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of TNF-a and hs-CRP. Timepoint: Patients in the first group (control group) will receive the medication on the first day and will receive physiotherapy. After 90 days, serum levels of TNF-a and hs-CRP were also determined by ELISA. Method of measurement: Serum TNF-a and hs-CRP levels were also determined by ELISA.
- Secondary Outcome Measures
Name Time Method